“…Prognostic factors such as older age, proximal site, tumor size ≥ 10 cm, high cellularity, anaplasia, and > 2 mitoses per 10 high-power fields are associated with decreased survival (9,10). First-line treatment is wide surgical resection, with or without adjuvant radiotherapy, as the tumor has a poor responsiveness to chemotherapy (1,6). Despite high metastatic potential, prolonged survival is common with 10-yr survival rates of 65% to 88% (8).…”